Optionally convertible debentures · Healthtech

Neuberg Diagnostics secures ₹940 crore from Kotak fund

The diagnostics network will use the financing to acquire regional businesses and expand services.

Kotak Strategic Situations India Fund II announced a ₹940 crore investment in Neuberg Diagnostics on 10 January 2025. The fund is managed by Kotak Alternate Asset Managers.

The capital will support acquisitions and the integration of regional diagnostic businesses, alongside expansion in personalised medicine and integrated diagnostics. Neuberg operates a laboratory network offering routine tests and specialised services including genomics.

Octus’s transaction research identifies the financing as optionally convertible debentures. The investment announcement also described plans to prepare the business for an initial public offering.

Use of funds

Acquisitions and integration of regional diagnostics businesses

Personalized medicine and integrated diagnostics

Funding history

Optionally convertible debentures · This round₹9.4B

Sources

  1. Original investment announcementkotakalternateasset.com · Jan 10, 2025
  2. Original investment announcementvarde.com